Loss of motivation and frontal dysfunction. Role of the white matter change;Démotivation et dysfonctionnements frontaux chez le sujet âgé: Place de la leucoaraïose

Encephale

Volumn 30, Issue 1, 2004, Pages 52-59

  Thomas, P ^a   Hazif Thomas, C ^a   Saccardy, F ^b   Vandermarq, P ^b  

^a Service Universitaire de Psychogeriatrie   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Brain; Dementia; Frontal dysfunction; Loss of motivation; Radiology; White matter change

Indexed keywords

AGED; AGING; APATHY; ARTICLE; BRAIN DYSFUNCTION; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FRONTAL CORTEX; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NEUROPSYCHOLOGICAL TEST; WHITE MATTER;

EID: 1642364106     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0013-7006(04)95416-4     Document Type: Article

References (56)

1. AIZENSTEIN HJ, NEBES RD, MELTZER CC et al. The relation of White Matter Hyperintensities to implicit learning in healthy older adults. Int J Geriatr Psychiatry 2002; 17 (7): 664-9.
2. ALEXOPOULOS G, YOUNG RC, SHAMOIAN C. Cornell scale for depression in dementia. Biol Psychiatry 1988; 23 (3): 271-84.
3. ALEXOPOULOS GS, MEYERS BS, YOUNG RC et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000; 57 (3): 285-90.
4. AMAR K, BUCKS RS, LEWIS T et al. The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type. Age Ageing 1996; 25 (6): 443-8.
5. BARTRES-FAZ D, CLEMENTE IC, JUNQUE C. Modification de la substance blanche et performance cognitive chez la personne âgée. Rev Neurol 2001; 33 (4): 347-53.
6. BENOIT R, ROBERT P. Démences et hypothèses étiopathogéniques. Psychiatrie du sujet âgé. Léger JM, Clément JP, Wertheimer J, eds. 1999; 14: 157-8.
7. BILLON R, CHANTOIN S, HAZIF-THOMAS C et al. Validité et fiabilité d'une échelle d'appréciation de la démotivation. An Gerontol 2001; 16: 49-60.
8. BLENNOW K, WALLIN A, UHLEMANN C et al. White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand 1991; 83 (3): 187-93.
9. BRONGE L. Magnetic resonance imaging in dementia. A study of brain white matter changes. Acta Radiol 2002 (Suppl); 428: 1-32.
10. CAMUS V, SCHMITT L, OUSSET PJ et al. Dépression et démence: contribution à la validation française de deux échelles de dépression: Cornell scale for depression in dementia et Dementia mood assessment scale. Encephale 1995; XXI: 201-8.
11. CHABRIAT H, PAPPATA S, OSTERGAARD L et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000; 31 (8): 1904-12.
12. CHANTOIN-MERLET S, HAZIF-THOMAS C, THOMAS P et al. Dépendance, démotivation et dysfonctionnements frontaux chez le sujet âgé. An Gerontol 2002; 17: 215-32.
13. CLARKE R, JOACHIM C, ESIRI M et al. Leukoaraiosis at presentation and disease progression during follow-up in histologically confirmed cases of dementia. Ann N Y Acad Sci 2000; 903: 497-500.
14. DAVOUS P, DELACOURTE A. Maladie d'Alzheimer. Encycl Med Chir 1999; 17-056-A10.
15. DE GROOT JC, DE LEEUW FE, OUDKERK M et al. Cerebral white matter lesions and cognitive function. The Rotterdam Scan Study. Ann Neurol 2000; 47: 145-51.
16. DE LEEUW FE, DE GROOT JC, OUDKERK M et al. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999; 46 (6): 827-33.
17. DE LEEUW FE, DE GROOT JC, BOTS ML et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol 2000; 247: 291-6.
18. DUBOIS B, SLACHEVSKY A, LITVAN I et al. The FAB: a frontal assessment battery at bedside. Neurology 2000; 55: 1621-6.
19. FAZEKAS F, SCHMIDT R, SCHELTENS P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord 1998; 9 (Suppl 1): 2-5.
20. FAZEKAS F, BARKHOF F, WAHLUND LO et al. CT and MRI rating of white matter lesions. Cerebrovasc Dis 2002; 2: 31-6.
21. FILLEY CM, THOMPSON LL, SZE CI et al. White matter dementia in CADASIL. J Neurol Sci 1999; 163 (2): 163-7.
22. FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12 (3): 189-98.
23. GALLARDA T, LÔO H. Hypofrontalité et vieillissement cérébral. Rev Fr Psychiatr Psychol Med 1999; 27: 62-6.
24. GEORGE AE, DE LEON MJ, FERRIS SH et al. Parenchymal CT correlates of senile dementia (Alzheimer disease): loss of gray-white matter discriminability. AJNR Am J Neuroradiol 1981; 2 (3): 205-13.
25. HAZIF-THOMAS C, THOMAS P, SUTTER J. Anticipation et motivation dans l'âge avancé. Ann Med Psychol 1997; 55: 517-22.
26. HAZIF-THOMAS C, CHANTOIN-MERLET S, THOMAS P et al. Démotivation et dysfonctionnements frontaux chez le sujet âgé. Encephale 2002; XXVIII: 533-41.
27. KIVIPELTO M, HELKALA EL, HANNINEN T et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001; 56 (12): 1683-9.
28. LONGSTRETH WTJ, ARNOLD AM, MANOLIO TA et al. Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Collaborative Research Group. Neuroepidemiology 2000; 19 (1): 30-42.
29. MALONE MJ, SZOKE MC. Neurochemical changes in white matter. Aged human brain and Alzheimer's disease. Arch Neurol 1985; 42 (11): 1063-6.
30. MARIN RS. Differential diagnosis of apathy and related disorders of diminished motivation. Psychiatr Ann 1997; 27 (1): 30-3.
31. MENDES RIBEIRO HK, BARNETSON LP, HOGERVORST E et al. A new visual rating scale for white matter low attenuation on CT. Eur Neurol 2001; 45 (3): 140-4.
32. MORRIS JC, STORANDT M, MILLER JP et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58 (3): 397-405.
33. NOBLER MS, ROOSE SP, PROHOVNIK I et al. Regional cerebral blood flow in mood disorders, V. Effects of antidepressant medication in late-life depression. Am J Geriatr Psychiatry 2000; 8 (4): 289-96.
34. PALMER K, WANG HX, BACKMAN L et al. Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am J Psychiatry 2002; 159 (3): 436-42.
35. PANTONI L, GARCIA JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 1995; 26 (7):1293-301.
36. PANTONI L, GARCIA JH, BROWN GG. Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci 1996; 135 (2): 131-9.
37. PASQUIER F, HENON H, LEYS D. Relevance of white matter changes to pre- and poststroke dementia. Ann N Y Acad Sci 2000; 903: 466-9.
38. PEILA R, WHITE LR, PETROVICH H et al. Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study. Stroke 2001; 32 (12): 2882-9.
39. PETERSEN RC, SMITH GE, WARING SC. Mild Cognitive Impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-8.
40. POLIDORI MC, MENCULINI G, SENIN U et al. Dementia, depression and parkinsonism: a frequent association in the elderly. J Alzheimers Dis 2001; 3 (6): 553-62.
41. REID W, BROE G, CREASEY H et al. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population. Arch Neurol 1996; 53 (10): 1056-61.
42. REZEK DL, MORRIS JC, FULLING KH et al. Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging. Neurology 1987; 37 (8): 1365-8.
43. ROBINSON RG, STARKSTEIN SE. Mood disorders following stroke: new findings and future directions. J Geriatr Psychiatry 1989; 22 (1): 1-15.
44. ROBINSON RG, STARKSTEIN SE. Neuropsychiatric aspects of cerebrovascular disorders. In: Yudofsky SC, Hales RE, eds. The American Psychiatric Text Book of Neuropsychiatry. Washington DC: American Psychiatric Press, 1997: 607-33.
45. SCHELTENS P, ERKINJUNTI T, LEYS D et al. White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998; 39 (2): 80-9.
46. SIERRA C. Cerebral white matter lesions in essential hypertension. Curr Hypertens Rep 2001; 3 (5): 429-33.
47. SIMPSON S, BALDWIN RC, JACKSON A et al. Is the clinical expression of late-life depression influenced by brain changes? MRI subcortical neuroanatomical correlates of depressive symptoms. Int Psychogeriatr 2000; 12 (4): 425-34.
48. STARKSTEIN SE, SABE L, VASQUEZ S et al. Neurochirurgical, psychiatric, and cerebral perfusion correlates of leucoaraïosis in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997; 63: 66-73.
49. STEFFENS DC, KRISHNAN KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43: 705-12.
50. STEFFENS DC, HELMS MJ, KRISHNAN KR et al. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 1999; 30 (10): 2159-66.
51. STEINGART A, LAU K, FOX A et al. The significance of white matter lucencies on CT scan in relation to cognitive impairment. Can J Neurol Sci 1986; 13 (Suppl 4): 383-4.
52. TEI H, MIYAZAKI A, IWATA M et al. Early-stage Alzheimer's disease and multiple subcortical infarction with mild cognitive impairment: neuropsychological comparison using an easily applicable test battery. Dement Geriatr Cogn Disord 1997; 8 (6): 355-8.
53. VERMEER SE, VAN DIJK EJ, KOUDSTAAL P et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 2002; 51 (3): 285-9.
54. WAHLUND LO, BARKHOF F, FAZEKAS F et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 32: 1318-22.
55. WOLF H, ECKE GM, BETTIN S et al. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry 2000; 15 (9).
56. WONG TY, KLEIN R, SHARRETT AR et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002; 288 (1): 67-74.